eSupervisor Detail

About me

Experienced and research-driven Associate Professor in Pharmaceutics with a strong foundation in advanced drug delivery systems, Actively engaged in academic research and innovation, with ongoing PhD work focused on long-acting injectable formulations for neurological conditions such as ALS and spasticity. Proven ability to design experimental protocols, conduct in-vitro and in-vivo evaluations, and publish scientific literature bRecognized for excellence in teaching with a “Best Teacher” award

Interests: My research interests are centered on the design, development, and evaluation of advanced drug delivery systems aimed at enhancing therapeutic efficacy, patient compliance, and controlled drug release. I am particularly focused on long-acting depot formulations, microsphere-based systems, and biodegradable polymeric implants for the management of chronic and neurological disorders. My work emphasizes the use of biocompatible polymers such as poly(lactic-co-glycolic acid) (PLGA) to achieve sustained and predictable drug release profiles. A major area of my research involves the formulation and optimization of microsphere-loaded depot injections for drugs with short biological half-lives. I am currently working on the development of long-acting injectable formulations of tizanidine hydrochloride for the treatment of spasticity, targeting extended drug release over 14–30 days. This research includes addressing key formulation challenges such as low drug solubility at physiological pH, encapsulation efficiency, burst release control, and polymer degradation behavior. My approach integrates formulation optimization with systematic evaluation to ensure reproducibility and scalability. In addition to depot systems, I have a strong interest in lipid-based drug delivery approaches, including self-emulsifying and self-double emulsifying drug delivery systems (SEDDS/SDEDDS), to enhance the solubility and oral bioavailability of poorly water-soluble drugs. These systems offer promising strategies for improving the pharmacokinetic profiles of challenging drug candidates, and I am interested in their formulation, characterization, and performance evaluation. I am also actively engaged in the in vitro and in vivo evaluation of pharmaceutical formulations, including drug release kinetics, stability studies, and pharmacokinetic analysis. Establishing in vitro–in vivo correlation (IVIVC) is a key focus area, as it plays a critical role in predicting clinical outcomes and supporting regulatory approval. Additionally, I am interested in applying statistical and design of experiments (DoE) approaches to optimize formulation variables and improve product performance. Beyond formulation science, I am interested in the translation of research into practical and marketable healthcare solutions. My work includes the development of innovative products such as herbal gel formulations for pain and fever management, reflecting my inclination toward pharmaceutical entrepreneurship and product development. I am also keenly interested in regulatory aspects, scale-up processes, and SUPAC guidelines related to modified-release dosage forms. Furthermore, I aim to explore interdisciplinary approaches that integrate pharmaceutics with nanotechnology, advanced biomaterials, and innovative drug delivery platforms. My long-term goal is to contribute to the development of patient-centric, safe, and effective drug delivery systems that address unmet clinical needs and improve quality of life. Through a combination of academic research, innovation, and practical application, I strive to bridge the gap between laboratory research and industrial pharmaceutical development.